Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require “next-step” treatments: A VAST-D report

Journal of Affective Disorders

Volumn 206, Issue , 2016, Pages 232-240

  Zisook, Sidney ^a   Tal, Ilanit ^a   Weingart, Kimberly ^a   Hicks, Paul ^b   Davis, Lori L ^c,d   Chen, Peijun ^e   Yoon, Jean ^f   Johnson, Gary R ^g   Vertrees, Julia E ^h   Rao, Sanjai ^a   Pilkinton, Patricia D ^c,i   Wilcox, James A ^j   Sapra, Mamta ^c,k   Iranmanesh, Ali ^c,k   Huang, Grant D ^l   Mohamed, Somaia ^g,m  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Health Economics Resource Center   (United States)

^g VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^h NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

ⁱ Capstone College of Community Health Sciences   (United States)

^j UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^k VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^l VA Office of Research and Development   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Major Depressive Disorder; Treatment resistant depression; Veterans

Indexed keywords

CITALOPRAM; FLUOXETINE; SERTRALINE; VENLAFAXINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE;

ADULT; AGED; ARTICLE; BEREAVEMENT; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; PHYSICAL ABUSE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRY; SUICIDAL IDEATION; UNEMPLOYMENT; VETERAN; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ARIPIPRAZOLE; BUPROPION; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; UNITED STATES; VETERANS; YOUNG ADULT;

EID: 84979916679     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.07.023     Document Type: Article

References (61)

1. Akiskal, H.S., Benazzi, F., Perugi, G., Rihmer, Z., Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord. 85 (2005), 245–258.
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Arlington, VA.
3. Beck, A.T., Epstein, N., Brown, G., Steer, R.A., An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 56 (1988), 893–897.
4. Becker, M.E., Hertzberg, M.A., Moore, S.D., Dennis, M.F., Bukenya, D.S., Beckham, J.C., A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J. Clin. Psychopharmacol. 27 (2007), 193–197.
5. Boelen, P.A., Prigerson, H.G., Commentary on the inclusion of persistent complex bereavement-related disorder in DSM-5. Death Stud. 36 (2012), 771–794.
6. Brady, K.T., Killeen, T.K., Brewerton, T., Lucerini, S., Comorbidity of psychiatric disorders and posttraumatic stress disorder. J. Clin. Psychiatry 61:Suppl 7 (2000), 22–32.
7. Burnam, M.A., Meredith, L.S., Tanielian, T., Jaycox, L.H., Mental health care for Iraq and Afghanistan War Veterans. Health Aff. 28 (2009), 771–782.
8. Campbell, D.G., Felker, B.L., Liu, C.F., Yano, E.M., Kirchner, J.E., Chan, D., Rubenstein, L.V., Chaney, E.F., Prevalence of depression-PTSD comorbidity: implications for clinical practice guidelines and primary care-based interventions. J. Gen. Intern. Med. 22 (2007), 711–718.
9. Connolly, K.R., Thase, M.E., If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 71 (2011), 43–64.
10. Endicott, J., Nee, J., Harrison, W., Blumenthal, R., Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol. Bull. 29 (1993), 321–326.
11. Field, N.P., Filanosky, C., Continuing bonds, risk factors for complicated grief, and adjustment to bereavement. Death Stud. 34 (2010), 1–29.
12. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C., Fawcett, J., Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303 (2010), 47–53.
13. Gilmer, W.S., Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Luther, J., Howland, R.H., Yohanna, D., Khan, A., Alpert, J., Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr. Scand. 112 (2005), 425–433.
14. Greenberg, P.E., Fournier, A.A., Sisitsky, T., Pike, C.T., Kessler, R.C., The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J. Clin. Psychiatry 76 (2015), 155–162.
15. Guy, W., 1976. Clinical Global Impression Scale, ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD, pp. 218–222.
16. Hensley, P.L., Slonimski, C.K., Uhlenhuth, E.H., Clayton, P.J., Escitalopram: an open-label study of bereavement-related depression and grief. J. Affect. Disord. 113 (2009), 142–149.
17. Hirschfeld, R.M., Williams, J.B., Spitzer, R.L., Calabrese, J.R., Flynn, L., Keck, P.E. Jr., Lewis, L., McElroy, S.L., Post, R.M., Rapport, D.J., Russell, J.M., Sachs, G.S., Zajecka, J., Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am. J. Psychiatry 157 (2000), 1873–1875.
18. Ikin, J.F., McKenzie, D.P., Gwini, S.M., Kelsall, H.L., Creamer, M., McFarlane, A.C., Clarke, D.M., Wright, B., Sim, M., Major depression and depressive symptoms in Australian Gulf War veterans 20 years after the Gulf War. J. Affect. Disord. 189 (2016), 77–84.
19. Johnstone, J.M., Luty, S.E., Carter, J.D., Mulder, R.T., Frampton, C.M., Joyce, P.R., Childhood neglect and abuse as predictors of antidepressant response in adult depression. Depression Anxiety 26 (2009), 711–717.
20. Judd, L.L., Paulus, M.J., Schettler, P.J., Akiskal, H.S., Endicott, J., Leon, A.C., Maser, J.D., Mueller, T., Solomon, D.A., Keller, M.B., Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?. Am. J. Psychiatry 157 (2000), 1501–1504.
21. Kemp, A.H., Gordon, E., Rush, A.J., Williams, L.M., Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr. 13 (2008), 1066–1086 quiz 1087–1068.
22. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003), 3095–3105.
23. Kessler, R.C., Magee, W.J., Childhood adversities and adult depression: basic patterns of association in a US national survey. Psychol. Med. 23 (1993), 679–690.
24. Kessler, R.C., Sonnega, A., Bromet, E., Hughes, M., Nelson, C.B., Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 52 (1995), 1048–1060.
25. Klein, D.N., Arnow, B.A., Barkin, J.L., Dowling, F., Kocsis, J.H., Leon, A.C., Manber, R., Rothbaum, B.O., Trivedi, M.H., Wisniewski, S.R., Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression Anxiety 26 (2009), 701–710.
26. Kocsis, J.H., Gelenberg, A.J., Rothbaum, B., Klein, D.N., Trivedi, M.H., Manber, R., Keller, M.B., Howland, R., Thase, M.E., Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J. Affect. Disord. 110 (2008), 55–61.
27. Levine, J., Schooler, N.R., SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol. Bull. 22 (1986), 343–381.
28. Linn, B.S., Linn, M.W., Gurel, L., Cumulative illness rating scale. J. Am. Geriatr. Soc. 16 (1968), 622–626.
29. Management of MDD Working Group, 2009. VA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder (MDD), In: Department of Defense and Department of Veterans Affairs (Ed.), Washington, DC.
30. Marmar, C.R., Schlenger, W., Henn-Haase, C., Qian, M., Purchia, E., Li, M., Corry, N., Williams, C.S., Ho, C.L., Horesh, D., Karstoft, K.I., Shalev, A., Kulka, R.A., Course of posttraumatic stress disorder 40 years after the Vietnam War: findings from the National Vietnam Veterans Longitudinal Study. JAMA Psychiatry 72 (2015), 875–881.
31. McGahuey, C.A., Gelenberg, A.J., Laukes, C.A., Moreno, F.A., Delgado, P.L., McKnight, K.M., Manber, R., The Arizona Sexual Experience Scale (ASEX): reliability and validity. J. Sex Marital Ther. 26 (2000), 25–40.
32. McIntyre, R.S., Implementing treatment strategies for different types of depression. J. Clin. Psychiatry 77:Suppl 1 (2016), 9–15.
33. Miller, M.D., Paradis, C.F., Houck, P.R., Mazumdar, S., Stack, J.A., Rifai, A.H., Mulsant, B., Reynolds, C.F. 3rd, Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 41 (1992), 237–248.
34. Mohamed, S., Johnson, G.R., Vertrees, J.E., Guarino, P.D., Weingart, K., Young, I.T., Yoon, J., Gleason, T.C., Kirkwood, K.A., Kilbourne, A.M., Gerrity, M., Marder, S., Biswas, K., Hicks, P., Davis, L.L., Chen, P., Kelada, A., Huang, G.D., Lawrence, D.D., LeGwin, M., Zisook, S., The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: rationale and design considerations. Psychiatry Res. 229 (2015), 760–770.
35. Mohamed, S., Leslie, D.L., Rosenheck, R.A., Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs. J. Clin. Psychiatry 70 (2009), 906–912.
36. Nanni, V., Uher, R., Danese, A., Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am. J. Psychiatry 169 (2012), 141–151.
37. Nemeroff, C.B., Heim, C.M., Thase, M.E., Klein, D.N., Rush, A.J., Schatzberg, A.F., Ninan, P.T., McCullough, J.P. Jr., Weiss, P.M., Dunner, D.L., Rothbaum, B.O., Kornstein, S., Keitner, G., Keller, M.B., Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc. Natl. Acad. Sci. USA 100 (2003), 14293–14296.
38. Noto, C., Rizzo, L.B., Mansur, R., Brietzke, E., Maes, M., Major depression: an immune-inflammatory disorder. Immunol. Psychiatry, 2015, 147–159.
39. Posner, K., Melvin, G.A., Stanley, B., Oquendo, M.A., Gould, M., Factors in the assessment of suicidality in youth. CNS Spectr. 12 (2007), 156–162.
40. Rosenheck, R., 2004. Mental health and substance abuse services for veterans: Experience with mental health performance evaluation in the Department of Veterans Affairs. Institute of Medicine Committee on Crossing the Quality Chasm: Adaptation to mental health and addictive disorders, pp. 423–482.
41. Rush, A.J., STAR*D: what have we learned?. Am. J. Psychiatry 164 (2007), 201–204.
42. Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N., Markowitz, J.C., Ninan, P.T., Kornstein, S., Manber, R., Thase, M.E., Kocsis, J.H., Keller, M.B., The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 54 (2003), 573–583.
43. Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Stewart, J.W., Warden, D., Niederehe, G., Thase, M.E., Lavori, P.W., Lebowitz, B.D., McGrath, P.J., Rosenbaum, J.F., Sackeim, H.A., Kupfer, D.J., Luther, J., Fava, M., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163 (2006), 1905–1917.
44. Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Stewart, J.W., Nierenberg, A.A., Thase, M.E., Ritz, L., Biggs, M.M., Warden, D., Luther, J.F., Shores-Wilson, K., Niederehe, G., Fava, M., Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl. J. Med. 354 (2006), 1231–1242.
45. Rush, A.J., Zimmerman, M., Wisniewski, S.R., Fava, M., Hollon, S.D., Warden, D., Biggs, M.M., Shores-Wilson, K., Shelton, R.C., Luther, J.F., Thomas, B., Trivedi, M.H., Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J. Affect. Disord. 87 (2005), 43–55.
46. Rytwinski, N.K., Scur, M.D., Feeny, N.C., Youngstrom, E.A., The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J. Trauma Stress 26 (2013), 299–309.
47. Shear, K.M., Jackson, C.T., Essock, S.M., Donahue, S.A., Felton, C.J., Screening for complicated grief among project liberty service recipients 18 months after september 11, 2001. Psychiatr. Serv. 57 (2006), 1291–1297.
48. Shear, M.K., Simon, N., Wall, M., Zisook, S., Neimeyer, R., Duan, N., Reynolds, C., Lebowitz, B., Sung, S., Ghesquiere, A., Gorscak, B., Clayton, P., Ito, M., Nakajima, S., Konishi, T., Melhem, N., Meert, K., Schiff, M., O'Connor, M.F., First, M., Sareen, J., Bolton, J., Skritskaya, N., Mancini, A.D., Keshaviah, A., Complicated grief and related bereavement issues for DSM-5. Depression Anxiety 28 (2011), 103–117.
49. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59:Suppl 20 (1998), 22–33 quiz 34–57.
50. Shelton, R.C., Osuntokun, O., Heinloth, A.N., Corya, S.A., Therapeutic options for treatment-resistant depression. CNS Drugs 24 (2010), 131–161.
51. Tanielian, T., Haycox, L.H., Schell, T.L., Marshall, G.N., Audrey Burnam, M., Eibner, C., Karney, B.R., Meredith, L.S., Ringel, J.S., Vaiana, M.E., Invisible wounds of war. Summary and recommendations for addressing psychological and cognitive injuries. 2008, Rand Corp, Santa Monica, CA.
52. Trivedi, M.H., Fava, M., Wisniewski, S.R., Thase, M.E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A.A., Lebowitz, B.D., Biggs, M.M., Luther, J.F., Shores-Wilson, K., Rush, A.J., Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. 354 (2006), 1243–1252.
53. Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., Norquist, G., Howland, R.H., Lebowitz, B., McGrath, P.J., Shores-Wilson, K., Biggs, M.M., Balasubramani, G.K., Fava, M., Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163 (2006), 28–40.
54. Ursano, R.J., Kessler, R.C., Stein, M.B., Naifeh, J.A., Aliaga, P.A., Fullerton, C.S., Sampson, N.A., Kao, T.C., Colpe, L.J., Schoenbaum, M., Cox, K.L., Heeringa, S.G., Suicide attempts in the US Army during the Wars in Afghanistan and Iraq, 2004 to 2009. JAMA Psychiatry 72 (2015), 917–926.
55. Younes, N., Hardy-Bayle, M.C., Falissard, B., Kovess, V., Chaillet, M.P., Gasquet, I., Differing mental health practice among general practitioners, private psychiatrists and public psychiatrists. BMC Public Health, 5, 2005, 104.
56. Zimmerman, M., Martinez, J., Attiullah, N., Friedman, M., Toba, C., Boerescu, D.A., Why do some depressed outpatients who are not in remission according to the Hamilton Depression Rating Scale nonetheless consider themselves to be in remission?. Depression Anxiety 29 (2012), 891–895.
57. Zimmerman, M., McGlinchey, J.B., Posternak, M.A., Friedman, M., Boerescu, D., Attiullah, N., Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined. Psychiatry Res. 141 (2006), 185–191.
58. Zimmerman, M., McGlinchey, J.B., Posternak, M.A., Friedman, M., Boerescu, D., Attiullah, N., Remission in depressed outpatients: more than just symptom resolution?. J. Psychiatr. Res. 42 (2008), 797–801.
59. Zisook, S., Corruble, E., Duan, N., Iglewicz, A., Karam, E.G., Lanouette, N., Lebowitz, B., Pies, R., Reynolds, C., Seay, K., Katherine Shear, M., Simon, N., Young, I.T., The bereavement exclusion and DSM-5. Depression Anxiety 29 (2012), 425–443.
60. Zisook, S., Ganadjian, K., Moutier, C., Prather, R., Rao, S., Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned. J. Clin. Psychiatry 69 (2008), 1184–1185.
61. Zivin, K., Yosef, M., Miller, E.M., Valenstein, M., Duffy, S., Kales, H.C., Vijan, S., Kim, H.M., Associations between depression and all-cause and cause-specific risk of death: a retrospective cohort study in the Veterans Health Administration. J. Psychosom. Res. 78 (2015), 324–331.